SS Innovations International Inc (SSII)

NASD · Healthcare · Medical Devices · USA

SS Innovations International Inc is a micro cap company (market value under $300 million) in the Medical Devices industry.

SS Innovations International Inc designs and manufactures the SSi Mantra, a surgical robotic system for procedures across multiple medical specialties. The company generates revenue from system sales via outright purchase, installment payments, and pay-per-procedure models, plus recurring income from instruments, accessories and services. Operating primarily in India with installations in several other countries, it sells systems directly and through distributors.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the SS Innovations International Inc stock.

Our verdict on SSII

Overvalued: intrinsic value $0.38 per share, market price $1.33, margin of safety -249.4% (as of 2026-11-17).

A 1.6x revenue multiple, discounted for its losses, values the shares at $0.38; the price of $1.33 is 249% above that value.

ETFs with the most weight in SSII

More on SSII

Browse

Peers in Medical Devices

All 140 Medical Devices stocks

Cheaper than SSII in Medical Devices

45 more in this industry show a wider margin of safety.

Is SSII undervalued or overvalued?

SSII is overvalued (as of the 2026-11-17 close). A 1.6x revenue multiple, discounted for its losses, values the shares at $0.38; the price of $1.33 is 249% above that value.

What is the intrinsic value of SSII?

$0.38 per share (as of the 2026-11-17 close), against a market price of $1.33. That is a margin of safety of -249.4%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.